New insights in the pathophysiology of acute myocardial infarction detectable by a contemporary troponin assay

Clinical Biochemistry

Volumn 46, Issue 12, 2013, Pages 999-1006

  Ferraro, Simona ^a,b   Biganzoli, Elia ^c,d   Marano, Giuseppe ^c,d   Santagostino, Matteo ^b   Boracchi, Patrizia ^c,d   Panteghini, Mauro ^a   Bongo, Angelo S ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Analytical sensitivity; Assay; Biological interaction; Myocardial pathophysiology; Troponin

Indexed keywords

TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGING; ARTICLE; CORONARY ARTERY DISEASE; EMERGENCY WARD; FEMALE; GROUPS BY AGE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACS; ACUTE CORONARY SYNDROME; ACUTE MYOCARDIAL INFARCTION; ANALYTICAL COEFFICIENT OF VARIATION; ANALYTICAL SENSITIVITY; ASSAY; BIOLOGICAL INTERACTION; CAD; CARDIAC CARE UNIT; CARDIAC TROPONIN I; CCU; CI; CK-MB; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; CREATINE KINASE MB ISOENZYME; CTNI; CTNI V; CVA; ECG; ED; ELECTROCARDIOGRAM; EMERGENCY DEPARTMENT; LIMIT OF DETECTION; LOD; MI; MYOCARDIAL PATHOPHYSIOLOGY; NO ST-ELEVATION AT ELECTROCARDIOGRAM MYOCARDIAL INFARCTION; NSTEMI; PCI; PERCUTANEOUS CORONARY INTERVENTION; ST-ELEVATION MYOCARDIAL INFARCTION; STEMI; TROPONIN; VELOCITY OF CTNI RELEASE;

ADULT; AGED; AGED, 80 AND OVER; CHEMISTRY, CLINICAL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PERCUTANEOUS CORONARY INTERVENTION; TIME FACTORS; TROPONIN I;

EID: 84880584943     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.03.026     Document Type: Article

References (38)

1. Kilic T., Oner G., Ural E., Yumuk Z., Sahin T., Bildirici U., et al. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome. Atherosclerosis 2009, 207:552-558.
2. Okmen E., Kasikcioglu H., Sanli A., Uyarel H., Cam N. Correlations between cardiac troponin I, cardiac troponin T and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker. J Invasive Cardiol 2005, 17:63-67.
3. Thygesen K., Alpert J.S., White H.D., Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction. Circulation 2007, 116:2634-2653.
4. Tzivoni D., Koukoui D., Guetta V., Novack L., Cowing G., CASTEMI Study Investigators Comparison of troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty. Am J Cardiol 2008, 101:753-757.
5. Ferraro S., Lupi A., Marano G., Rossi L., Ciardi L., Vendramin C., et al. Different patterns of NT-proBNP secretion in acute coronary syndromes. Clin Chim Acta 2009, 402:176-181.
6. Di Stefano R., Di Bello V., Barsotti M.C., Grigoratos C., Armani C., Dell'Omodarme M., et al. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models. Biomed Pharmacother 2009, 63:773-780.
7. Kuch B., von Scheidt W., Kling B., Heier M., Hoermann A., Meisinger C. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction. Am J Cardiol 2008, 102:1125-1130.
8. Casals G., Filella X., Bedini J.L. Evaluation of a new ultrasensitive assay for cardiac troponin I. Clin Biochem 2007, 40:1406-1413.
9. Apple F.S. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009, 55:1303-1306.
10. Clerico A., Fortunato A., Ripoli A., Prontera C., Zucchelli G.C., Emdin M. Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations. Clin Chem Lab Med 2008, 46:804-808.
11. Katritsis D.G., Siontis G.C., Kastrati A., van't Hof A.W., Neumann F.J., Siontis K.C., et al. Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes. Eur Heart J 2011, 32:32-40.
12. Antman E.M., Hand M., Armstrong P.W., Bates E.R., Green L.A., Halasyamani L.K., et al. 2007 focused update of the ACC/AHA 2004 Guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008, 117:296-329.
13. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey D.E., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2007, 116:e148-e304.
14. Cleveland W.S., Grosse E., Shyu W.M. Local regression models. Chapter 8 of statistical models in S 1992, Wadsworth & Brooks/Cole. J.M. Chambers, T.J. Hastie (Eds.).
15. Harrell F.E., Lee K.L., Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387.
16. De Luca G., Suryapranata H., Ottervanger J.P., Antman E.M. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction. Circulation 2004, 109:1223-1225.
17. Brodie B.R., Webb J., Cox D.A., Qureshi M., Kalynych A., Turco M., et al. Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD trial). Am J Cardiol 2007, 99:1680-1686.
18. Parikh S.V., de Lemos J.A. Biomarkers in cardiovascular disease: integrating pathophysiology into clinical practice. Am J Med Sci 2006, 332:186-197.
19. Ogawa A., Seino Y., Yamashita T., Ogata K., Takano T. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome. Circ J 2006, 70:1372-1378.
20. Apple F.S., Smith S.W., Pearce L.A., Murakami M.M. Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-ultra assay. Clin Biochem 2012, 45:711-713.
21. Lundergan C.F., Reiner J.S., Ross A.M. How long is too long? Association of time delay to successful reperfusion and ventricular function outcome in acute myocardial infarction. Am Heart J 2002, 144:456-462.
22. Boersma E., Maas A.C.P., Deckers J.W., Simoons M.L. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996, 348:771-775.
23. ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction - executive summary. A report of ACC/AHA Task Force on Practice Guidelines (writing committee to revise the 1999 Guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004, 44:671-719.
24. Nguyen H.L., Saczynski J.S., Gore J.M., Goldberg R.J. Age and sex differences in duration of prehospital delay in patients with acute myocardial infarction: a systematic review. Circ Cardiovasc Qual Outcomes 2010, 3:82-92.
25. Saczynski J.S., Yarzebski J., Lessard D., Spencer F.A., Gurwitz J.H., Gore J.M., et al. Trends in prehospital delay in patients with acute myocardial infarction (from the Worcester Heart Attack Study). Am J Cardiol 2008, 102:1589-1594.
26. Ellis A.K., Saran B.R. Kinetics of myoglobin release and prediction of myocardial myoglobin depletion after coronary artery reperfusion. Circulation 1989, 80:676-683.
27. Christenson R.H., Ohman E.M., Clemmensen P., Grande P., Toffaletti J., Silverman L.M., et al. Characteristics of creatine kinase-MB and MB isoforms in serum after reperfusion in acute myocardial infarction. Clin Chem 1989, 35:2179-2185.
28. Remppis A., Scheffold T., Karrer O., Zehelein J., Hamm C., Grünig E., et al. Assessment of reperfusion of the infarct zone after acute myocardial infarction by serial cardiac troponin T measurements in serum. Br Heart J 1994, 71:242-248.
29. Katus H.A., Diederich K.W., Scheffold T., Uellner M., Schwarz F., Kübler W. Non-invasive assessment of infarct reperfusion: the predictive power of the time to peak value of myoglobin, CKMB, and CK in serum. Eur Heart J 1988, 9:619-624.
30. Cobb F.R., Bache R.J., Rivas F., Greenfield J.C. Local effects of acute cellular injury on regional myocardial blood flow. J Clin Invest 1976, 57:1359-1368.
31. Mohanlal R.W., Mauve I., Zoet A.C., van der Laarse A. Reperfusion induced enzyme release: washout effect or manifestation of reperfusion damage?. Cardiovasc Res 1988, 22:603-610.
32. Xu J., Song Y.B., Hahn J.Y., Chang S.A., Lee S.C., Choe Y.H., et al. Comparison of magnetic resonance imaging findings in non-ST-segment elevation versus ST-segment elevation myocardial infarction patients undergoing early invasive intervention. Int J Cardiovasc Imaging 2011, [Epub ahead of print]. 10.1007/s10554-011-9975-2.
33. Venge P., Johnston N., Lagerqvist B., Wallentin L., Lindahl B. Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II Substudy. Clin Chem 2003, 49:880-886.
34. Vasikaran S.D., Bima A., Botros M., Sikaris K.A. Cardiac troponin testing in the acute care setting: ordering, reporting, and high sensitivity assays-an update from the Canadian society of clinical chemists (CSCC); the case for age related acute myocardial infarction (AMI) cut-offs. Clin Biochem 2012, 45:513-514.
35. Tomai F., Crea F., Chiariello L., Gioffrè P.A. Ischemic preconditioning in humans: models, mediators, and clinical relevance. Circulation 1999, 100:559-563.
36. Jenkins D.P., Pugsley W.B., Alkhulaifi A.M., Kemp M., Hooper J., Yellon D.M. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997, 77:314-318.
37. Iliodromitis E.K., Kyrzopoulos S., Paraskevaidis I.A., Kolocassides K.G., Adamopoulos S., Karavolias G., et al. Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning?. Heart 2006, 92:1821-1826.
38. Hong D.M., Jeon Y., Lee C.S., Kim H.J., Lee J.M., Bahk J.H., et al. Effects of remote ischemic preconditioning with postconditioning in patients undergoing off-pump coronary artery bypass surgery-randomized controlled trial. Circ J 2012, 76:884-890.